Investing Profile

Vangelis Vergetis

AngelCEOFounderInvestor
Working on the intersection of data science and healthcare
epikast.comNew York, New York
Photo of Vangelis Vergetis, Eucrates Biomedical Acquisition Corp

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
McKinsey & Company Network
141 CONNECTIONS
University of Pennsylvania Network
141 CONNECTIONS
Cornell University Network
125 CONNECTIONS
cb
$100.0M - $400.0M
$200.0M
2
CompanyStageDateRound SizeTotal Raised
Epikast, Inc.
Series AFeb 2023
Intelligencia, Inc.
AngelJul 2018
Companies in the intersection of data science and healthcare. On the earlier/smaller side, I typically consider $50-100K tickets as an angel investor. For more mature companies that are looking to go public, I can lead $100M+ investments in the form of a SPAC merger.
CEO Epikast, Inc.Present
Board member Eucrates Biomedical Acquisition Corp2020 - Present
Member YPO - Young Presidents' Organization2020 - Present
Board member & member of the Executive Committee Alliance for Artificial Intelligence in Healthcare (AAIH)2019 - 2023
Co-founder & CEO Intelligencia, Inc.2018 - 2022
Partner Hakluyt2014 - 2018
Associate partner McKinsey & Company2006 - 2014
Cornell University BS Computer Science & Electrical Engineering
University of Pennsylvania PhD Electrical & Systems Engineering